Your browser doesn't support javascript.
loading
Inferior outcome after allogeneic transplant in first remission in high-risk AML patients who required more than two cycles of induction therapy.
Lim, Sara J; Lim, Matthew J; Raptis, Anastasios; Hou, Jing-Zhou; Farah, Rafic; Marks, Stanley M; Im, Annie; Dorritie, Kathleen; Sehgal, Alison; Agha, Mounzer; Felgar, Raymond; Lim, Seah H.
Afiliación
  • Lim SJ; Division of Hematology and Oncology, Adult Hematopoietic Stem Cell Transplant Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Lim MJ; Division of Hematology and Oncology, Adult Hematopoietic Stem Cell Transplant Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Raptis A; Division of Hematology and Oncology, Adult Hematopoietic Stem Cell Transplant Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Hou JZ; Division of Hematology and Oncology, Adult Hematopoietic Stem Cell Transplant Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Farah R; Division of Hematology and Oncology, Adult Hematopoietic Stem Cell Transplant Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Marks SM; Division of Hematology and Oncology, Adult Hematopoietic Stem Cell Transplant Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Im A; Division of Hematology and Oncology, Adult Hematopoietic Stem Cell Transplant Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Dorritie K; Division of Hematology and Oncology, Adult Hematopoietic Stem Cell Transplant Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Sehgal A; Division of Hematology and Oncology, Adult Hematopoietic Stem Cell Transplant Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Agha M; Division of Hematology and Oncology, Adult Hematopoietic Stem Cell Transplant Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Felgar R; Division of Hematology and Oncology, Adult Hematopoietic Stem Cell Transplant Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Lim SH; Division of Hematology and Oncology, Adult Hematopoietic Stem Cell Transplant Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Am J Hematol ; 90(8): 715-8, 2015 Aug.
Article en En | MEDLINE | ID: mdl-26010177
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Quimioterapia de Inducción / Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2015 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Quimioterapia de Inducción / Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2015 Tipo del documento: Article